Literature DB >> 10353731

Comparison of features of human lung cancer cell lines and their corresponding tumors.

I I Wistuba1, D Bryant, C Behrens, S Milchgrub, A K Virmani, R Ashfaq, J D Minna, A F Gazdar.   

Abstract

Although human lung tumor-derived cell lines play an important role in the investigation of lung cancer biology and genetics, there is no comprehensive study comparing the genotypic and phenotypic properties of lung cancer cell lines with those of the individual tumors from which they were derived. We compared a variety of properties of 12 human non-small cell lung carcinoma (NSCLC) cell lines (cultured for a median period of 39 months; range, 12-69) and their corresponding archival tumor tissues. There was, in general, an excellent concordance between the lung tumor cell lines and their corresponding tumor tissues for morphology (100%), the presence of aneuploidy (100%), immunohistochemical expression of HER2/neu (100%) and p53 proteins (100%), loss of heterozygosity at 13 chromosomal regions analyzed (97%) using 37 microsatellite markers, microsatellite alterations (MAs, 75%), TP53 (67%), and K-ras (100%) gene mutations. In addition, there was 100% concordance for the parental allele lost in all 115 comparisons of allelic losses. Some discrepancies were found; more aneuploid subpopulations of cells were detected in the cell lines as well as higher incidences of TP53 mutations (4 of 10 mutations not found in the tumors) and microsatellite alterations (two cell lines with MAs not detected in the tumors). Similar loss of heterozygosity frequencies by chromosomal regions and mean fractional allelic loss index were detected between successfully cultured and 40 uncultured lung tumors (0.45 and 0.49, respectively), indicating that both groups were similar. Our findings indicate that the NSCLC cell lines in the large majority of instances retain the properties of their parental tumors for lengthy culture periods. NSCLC cell lines appear very representative of the lung cancer tumor from which they were derived and thus provide suitable model systems for biomedical studies of this important neoplasm.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353731

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  31 in total

Review 1.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Authors:  Adi F Gazdar; Boning Gao; John D Minna
Journal:  Lung Cancer       Date:  2010-01-15       Impact factor: 5.705

2.  Establishment and characterization of a lung cancer cell line, SMC-L001, from a lung adenocarcinoma.

Authors:  So-Jung Choi; Hyeseon Lee; Chungyoul Choe; Yong-Sung Shin; Jinseon Lee; Sung-Hwan Moon; Jhingook Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-02-26       Impact factor: 2.416

Review 3.  Lung cancer cell lines as tools for biomedical discovery and research.

Authors:  Adi F Gazdar; Luc Girard; William W Lockwood; Wan L Lam; John D Minna
Journal:  J Natl Cancer Inst       Date:  2010-08-02       Impact factor: 13.506

4.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

5.  Imbalance in redox status is associated with tumor aggressiveness and poor outcome in lung adenocarcinoma patients.

Authors:  Leonardo Lisbôa da Motta; Carolina B Müller; Marco A De Bastiani; Guilherme A Behr; Fernanda S França; Ricardo F da Rocha; Juliane B Minotto; Rosalva T Meurer; Marilda C Fernandes; Adriana Roehe; Melissa M Markoski; Cristiano F Andrade; Mauro A A Castro; Fábio Klamt
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-22       Impact factor: 4.553

6.  Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.

Authors:  Shalini Makawita; Chris Smith; Ihor Batruch; Yingye Zheng; Felix Rückert; Robert Grützmann; Christian Pilarsky; Steven Gallinger; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2011-06-07       Impact factor: 5.911

Review 7.  Lung stem and progenitor cells in tissue homeostasis and disease.

Authors:  Kristen T Leeman; Christine M Fillmore; Carla F Kim
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

Review 8.  Circulating tumor cells and CDX models as a tool for preclinical drug development.

Authors:  Alice Lallo; Maximilian W Schenk; Kristopher K Frese; Fiona Blackhall; Caroline Dive
Journal:  Transl Lung Cancer Res       Date:  2017-08

9.  Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.

Authors:  Yogesh M Kulkarni; Vivian Suarez; David J Klinke
Journal:  BMC Cancer       Date:  2010-06-15       Impact factor: 4.430

10.  Cellular and molecular phenotypes of proliferating stromal cells from human carcinomas.

Authors:  E P Kopantzev; N A Vayshlya; M R Kopantseva; V I Egorov; M Pikunov; M V Zinovyeva; T V Vinogradova; I B Zborovskaya; E D Sverdlov
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.